Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (241-250 of 602) with videos related to

Pageof 61
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2006
Intraductal papillary mucinous neoplasms and chronic pancreatitisGiorgio Talamini, Giuseppe Zamboni, Roberto Salvia, et al.
Neuroendocrinology|December 9, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratificationGünter Klöppel, Anne Couvelard, Aurel Perren, et al.
Biochimica Et Biophysica Acta|February 7, 2013
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activityElisa Dalla Pozza, Carlotta Lerda, Chiara Costanzo, et al.
BMC Gastroenterology|May 8, 2020
Exosomal miRNA signatures of pancreatic lesionsCaterina Vicentini, Federica Calore, Giovanni Nigita, et al.
Chirurgia Italiana|March 5, 2003
[Integrated project for the translational research on pancreatic ductal carcinoma]Stefano Marcucci, Antonio Bonora, Massimo Falconi, et al.
The Biochemical Journal|January 24, 2013
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumoursM Luisa Campos, Víctor J Sánchez-Arévalo Lobo, Annie Rodolosse, et al.
Clinical and Experimental Dental Research|May 20, 2022
PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedsideRiccardo Nocini, Matteo Vianini, Ilaria Girolami, et al.
Oncoimmunology|August 17, 2017
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumorsSatyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, et al.
Neuroendocrinology|October 25, 2014
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two componentsMaria Scardoni, Emanuele Vittoria, Marco Volante, et al.
Pathologica|November 17, 2025
HER2-positive neuroendocrine breast carcinoma: a case study uncovers <i>CCND1</i>, <i>FGF19</i>, and <i>IGF1R</i> amplifications as new molecular driversMargherita Zordan, Elena Fiorio, Valeria Maffeis, et al.
Pageof 61

Showing results (241-250 of 602) with videos related to

Sort By:
Pageof 61
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2006
Intraductal papillary mucinous neoplasms and chronic pancreatitisGiorgio Talamini, Giuseppe Zamboni, Roberto Salvia, et al.
Neuroendocrinology|December 9, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratificationGünter Klöppel, Anne Couvelard, Aurel Perren, et al.
Biochimica Et Biophysica Acta|February 7, 2013
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activityElisa Dalla Pozza, Carlotta Lerda, Chiara Costanzo, et al.
BMC Gastroenterology|May 8, 2020
Exosomal miRNA signatures of pancreatic lesionsCaterina Vicentini, Federica Calore, Giovanni Nigita, et al.
Chirurgia Italiana|March 5, 2003
[Integrated project for the translational research on pancreatic ductal carcinoma]Stefano Marcucci, Antonio Bonora, Massimo Falconi, et al.
The Biochemical Journal|January 24, 2013
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumoursM Luisa Campos, Víctor J Sánchez-Arévalo Lobo, Annie Rodolosse, et al.
Clinical and Experimental Dental Research|May 20, 2022
PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedsideRiccardo Nocini, Matteo Vianini, Ilaria Girolami, et al.
Oncoimmunology|August 17, 2017
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumorsSatyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, et al.
Neuroendocrinology|October 25, 2014
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two componentsMaria Scardoni, Emanuele Vittoria, Marco Volante, et al.
Pathologica|November 17, 2025
HER2-positive neuroendocrine breast carcinoma: a case study uncovers <i>CCND1</i>, <i>FGF19</i>, and <i>IGF1R</i> amplifications as new molecular driversMargherita Zordan, Elena Fiorio, Valeria Maffeis, et al.
Pageof 61